Cheema, P.K.; Banerji, S.O.; Blais, N.; Chu, Q.S.-C.; Juergens, R.A.; Leighl, N.B.; Sacher, A.; Sheffield, B.S.; Snow, S.; Vincent, M.;
et al. Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC. Curr. Oncol. 2023, 30, 6473-6496.
https://doi.org/10.3390/curroncol30070476
AMA Style
Cheema PK, Banerji SO, Blais N, Chu QS-C, Juergens RA, Leighl NB, Sacher A, Sheffield BS, Snow S, Vincent M,
et al. Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC. Current Oncology. 2023; 30(7):6473-6496.
https://doi.org/10.3390/curroncol30070476
Chicago/Turabian Style
Cheema, Parneet K., Shantanu O. Banerji, Normand Blais, Quincy S.-C. Chu, Rosalyn A. Juergens, Natasha B. Leighl, Adrian Sacher, Brandon S. Sheffield, Stephanie Snow, Mark Vincent,
and et al. 2023. "Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC" Current Oncology 30, no. 7: 6473-6496.
https://doi.org/10.3390/curroncol30070476
APA Style
Cheema, P. K., Banerji, S. O., Blais, N., Chu, Q. S.-C., Juergens, R. A., Leighl, N. B., Sacher, A., Sheffield, B. S., Snow, S., Vincent, M., Wheatley-Price, P. F., Yip, S., & Melosky, B. L.
(2023). Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC. Current Oncology, 30(7), 6473-6496.
https://doi.org/10.3390/curroncol30070476
